Clinical Trial Update: DIabetic Retinopathy Candesartan Trials. [Phase 3]

View source ↗

Summary

Phase 3 trials evaluating candesartan for diabetic retinopathy in people with Type 1 diabetes have completed, and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy
• Type 1 Diabetes Mellitus

Drugs mentioned

• Candesartan (candesartan)

Snippet

Sponsor: AstraZeneca | Conditions: Type 1 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2014-06-03